Form 4: DexCom Director Bridgette P. Heller Reports Acquisition of 5,046 Shares

Director Bridgette P. Heller reports acquiring 5,046 shares of DexCom Inc. common stock through a restricted stock unit (RSU) award.

Summary

• On May 8, 2025, Bridgette P. Heller, a director of DexCom Inc., acquired 5,046 shares of common stock.
• The acquisition was through a restricted stock unit (RSU) award.
• The price per share was $0.
• Following the transaction, Heller directly owns 28,043 shares of DexCom Inc.
• The RSU award vests on the earlier of one year from the grant date or DexCom's 2026 Annual Meeting of Stockholders.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing indicating insider stock activity. The acquisition of shares by a director is generally viewed positively, but the document itself is simply a factual report.

Positives

• The acquisition of shares by a director signals confidence in the company's future prospects.

Future Outlook

The RSU award vests on the earlier of one year from the grant date or DexCom's 2026 Annual Meeting of Stockholders, indicating a future commitment to the company.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common in the healthcare technology industry.

Stakeholder Impact

• The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

DexCom, Director, Bridgette P. Heller, RSU, Stock Acquisition, Form 4, DXCM